Halozyme Therapeutics Inc./OS/Call [80]/JPMD
- BID
0.41
- ASK
0.56
- 2,000 Units2,000 Units
- 07/24, 10:48:20 AM
Product class
Warrant - Classic
Last exchange day
21/08/2026
Performance (1M)
-
Basis price
80.0000 [USD]
Cap
- []
Leverage
12.68
Delta
0.57
Agio p.a. in %
6.85 %
Implicit volatility
65.46 %
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.27 G | 0 Units |
| PRICE DETERMINATION TIME | 07/23/2026 / 12:14:53 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.27 | 0.27 |
| PREV. DAY'S PRICE | 0.36 | (07/22) |
| CHANGE DAY BEFORE | -0.09 | -25.00 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Indicators
| TIME OF CALCULATION | 11:35:14 AM (07/24/2026) |
| AGIO P.A. IN % | 6.85 % |
| LEVERAGE | 12.68 |
| DELTA | 0.57 |
| IMPLICIT VOLATILITY | 65.46 % |
| OMEGA | 7.18 |
| THETA | -0.71 |
| VEGA | 0.01 |
Master Data
| WKN | JY2PZL |
| ISIN | DE000JY2PZL8 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Leverage Product |
| PRODUCT CLASS | Warrant - Classic |
| PRODUCT NAME | Optionsschein auf Halozyme Therapeutics Inc. |
| ISSUER | J.P. Morgan SE |
| TRADING SEGMENT | - |
| OPTION TYPE | call |
| UNDERLYING | HALOZYME THERAPEUTICS INC COM USD0.001 |
| BASIS PRICE | 80.0000 [USD] |
| CAP | - [] |
| KNOCKIN LEVEL | - [-] |
| RANGE | - - - |
| MULTIPLIER | 0.10 |
| EXERCISE TYPE | American |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | EUR |
| SETTLEMENT CURRENCY | Euro |
| SMALLEST TRADABLE UNIT | 1.00 |
| MINIMUM QUOTATION EUR | 0.00 |
| MINIMUM QUOTATION UNITS | 0.00 |
| LAST VALUATION DAY | 21/08/2026 |
| PAYMENT DATE | 28/08/2026 |
| FIRST EXCHANGE DAY | 09/07/2026 |
| LAST EXCHANGE DAY | 21/08/2026 |
| TRADING HOURS | - |
| QUOTATION | - |
| ISSUE VOLUME | 30,000,000 |
| QUANTO | No |
Underlying
| WKN | A0DLHS |
| ISIN | US40637H1095 |
| SYMBOL | RV7 |
| NOMINAL CURRENCY | Euro |
| TYPE OF UNDERLYING | Equity |
| COUNTRY OF THE HOME STOCK EXCHANGE | Germany |
Issuer
| NAME | J.P. Morgan SE |
| ADDRESS | J.P. Morgan SE
Taunustor 1 (Taunusturm)
60310 Frankfurt am Main
Deutschland |
| EMAIL ADDRESS | kontakt.zertifikate@jpmorgan.com |
| SERVICE PHONE NUMBER | 069 71240 |
| URL | https://jpmorgan-zertifikate.de |
| DOCUMENTS | PRIIP / KID (english) |
Product Description
This (call) warrant is linked to Halozyme Therapeutics Inc., the underlying instrument, and has a term ending on August 28, 2026. This is a leveraged product, where the investor participates disproportionately in the positive and negative performance of the underlying. The investor has the right to exercise throughout the term of the warrant. Upon exercise, the redemption amount is calculated as the difference between the price of the underlying and the strike price, adjusted for the multiplier of 0.10. Exercise occurs automatically at the end of the term. If, at that point in time, the price of the underlying is below the strike price, the product will expire worthless.